OA
Oak Associates Portfolio holdings
AUM
$1.53B
This Quarter Return
-17.24%
1 Year Return
+20.93%
3 Year Return
+113.44%
5 Year Return
+164.39%
10 Year Return
+515.4%
AUM
$1.28B
AUM Growth
+$1.28B
(-22%)
Cap. Flow
+$33.1M
Cap. Flow
% of AUM
2.59%
Top 10 Holdings %
Top 10 Hldgs %
43.57%
Holding
141
New
3
Increased
13
Reduced
52
Closed
12
Top Buys
| 1 |
Amazon
AMZN
|
$88.7M |
| 2 |
Moderna
MRNA
|
$1.34M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
$1.27M |
| 4 |
Fortinet
FTNT
|
$942K |
| 5 |
Pfizer
PFE
|
$784K |
Top Sells
| 1 |
Apple
AAPL
|
$6.88M |
| 2 |
DraftKings
DKNG
|
$5.16M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$4.35M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$3.59M |
| 5 |
eBay
EBAY
|
$3.21M |
Sector Composition
| 1 | Technology | 41.48% |
| 2 | Healthcare | 16.66% |
| 3 | Communication Services | 14.06% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Financials | 11.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Pfizer
PFE
$141B
| $16.9M | 1.32% | 322,997 +14,946 | +5% | +$784K |
|
|
VMW
27
DELISTED
VMware, Inc
VMW
| $16.8M | 1.31% | 147,172 -24,988 | -15% | -$2.85M |
|
28
Labcorp
LH
$23.1B
| $16.2M | 1.27% | 69,328 -26 | -0% | -$6.09K |
|
29
Alcon
ALC
$39.5B
| $15.3M | 1.2% | 218,900 -28,408 | -11% | -$1.99M |
|
30
McKesson
MCK
$85.4B
| $14.8M | 1.16% | 45,515 -6,788 | -13% | -$2.21M |
|
31
Akamai
AKAM
$11.3B
| $13.7M | 1.07% | 149,740 | – | – |
|
32
Zimmer Biomet
ZBH
$21B
| $13M | 1.02% | 124,056 -615 | -0.5% | -$64.6K |
|
33
Salesforce
CRM
$245B
| $11.9M | 0.93% | 72,300 -11,731 | -14% | -$1.94M |
|
34
NetApp
NTAP
$22.6B
| $11.5M | 0.9% | 176,765 -20 | -0% | -$1.31K |
|
35
Accenture
ACN
$162B
| $11.4M | 0.89% | 40,902 -7,000 | -15% | -$1.94M |
|
36
Global Payments
GPN
$21.5B
| $11.3M | 0.88% | 101,704 +12 | +0% | +$1.33K |
|
37
Amdocs
DOX
$9.41B
| $9.11M | 0.71% | 109,403 | – | – |
|
38
Gentex
GNTX
$6.15B
| $8.04M | 0.63% | 287,392 | – | – |
|
39
Assurant
AIZ
$10.9B
| $7.41M | 0.58% | 42,876 +8 | +0% | +$1.38K |
|
40
Gilead Sciences
GILD
$140B
| $7.36M | 0.58% | 119,057 -1,609 | -1% | -$99.5K |
|
41
Check Point Software Technologies
CHKP
$20.7B
| $7.2M | 0.56% | 59,143 -6,000 | -9% | -$731K |
|
42
GSK
GSK
$79.9B
| $6.76M | 0.53% | 155,355 -20 | -0% | -$871 |
|
43
State Street
STT
$32.6B
| $6.71M | 0.52% | 108,817 -1,343 | -1% | -$82.8K |
|
44
Medtronic
MDT
$119B
| $6.61M | 0.52% | 73,626 | – | – |
|
45
Illumina
ILMN
$15.8B
| $6.45M | 0.5% | 35,000 +1,346 | +4% | +$248K |
|
46
Intuitive Surgical
ISRG
$170B
| $6.08M | 0.48% | 30,292 | – | – |
|
47
Paychex
PAYX
$50.2B
| $5.92M | 0.46% | 52,019 -5 | -0% | -$569 |
|
48
M/I Homes
MHO
$3.89B
| $4.94M | 0.39% | 124,540 -3,497 | -3% | -$139K |
|
49
Bank of New York Mellon
BK
$74.5B
| $4.78M | 0.37% | 114,533 +28 | +0% | +$1.17K |
|
50
Quest Diagnostics
DGX
$20.3B
| $4.19M | 0.33% | 31,480 | – | – |
|